Search Results

There are 15033 results for: content related to: Vaccine adjuvants: Current challenges and future approaches

  1. Role and Application of Adjuvants and Delivery Systems in Vaccines

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Rajesh K. Gupta

    Published Online : 25 NOV 2013, DOI: 10.1002/9780470571224.pse513

  2. New-Generation Vaccine Adjuvants

    Standard Article


    Derek T O'Hagan

    Published Online : 15 JUL 2015, DOI: 10.1002/9780470015902.a0020177.pub2

  3. Evaluation of Biocompatibility and Administration Site Reactogenicity of Polyanhydride-Particle-Based Platform for Vaccine Delivery

    Advanced Healthcare Materials

    Volume 2, Issue 2, February, 2013, Pages: 369–378, Lucas Huntimer, Amanda E. Ramer-Tait, Latrisha K. Petersen, Kathleen A. Ross, Katherine A. Walz, Chong Wang, Jesse Hostetter, Balaji Narasimhan and Michael J. Wannemuehler

    Version of Record online : 26 SEP 2012, DOI: 10.1002/adhm.201200181

  4. Adjuvants and Subunit Vaccines

    Standard Article

    Topley and Wilson's Microbiology and Microbial Infections

    Giuseppe Del Giudice and Rino Rappuoli

    Published Online : 15 MAR 2010, DOI: 10.1002/9780470688618.taw0126

  5. Discovery of Vaccine Adjuvants

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Fiona A. Sharp and Ed C. Lavelle

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse438

  6. Immunomodulators as adjuvants for vaccines and antimicrobial therapy

    Annals of the New York Academy of Sciences

    Volume 1213, Issue 1, December 2010, Pages: 46–61, Erin F. Nicholls, Laurence Madera and Robert E. W. Hancock

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1749-6632.2010.05787.x

  7. You have free access to this content
    Particulate inorganic adjuvants: recent developments and future outlook

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 3, March 2015, Pages: 426–449, Charlotte N. Maughan, Stephen G. Preston and Gareth R. Williams

    Version of Record online : 10 DEC 2014, DOI: 10.1111/jphp.12352

  8. Modern Subunit Vaccines: Development, Components, and Research Opportunities


    Volume 8, Issue 3, March 2013, Pages: 360–376, Dr. Peter Michael Moyle and Prof. Istvan Toth

    Version of Record online : 11 JAN 2013, DOI: 10.1002/cmdc.201200487

  9. Vaccines with aluminum-containing adjuvants: Optimizing vaccine efficacy and thermal stability

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 388–401, Tanya Clapp, Paul Siebert, Dexiang Chen and LaToya Jones Braun

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22284

  10. Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

    Volume 101B, Issue 1, January 2013, Pages: 91–98, Lucas Huntimer, Jennifer H. Wilson Welder, Kathleen Ross, Brenda Carrillo-Conde, Lynn Pruisner, Chong Wang, Balaji Narasimhan, Michael J. Wannemuehler and Amanda E. Ramer-Tait

    Version of Record online : 10 NOV 2012, DOI: 10.1002/jbm.b.32820

  11. You have free access to this content
    The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses

    European Journal of Immunology

    Volume 42, Issue 10, October 2012, Pages: 2709–2719, Andres Mori, Ewa Oleszycka, Fiona A. Sharp, Michelle Coleman, Yuki Ozasa, Manmohan Singh, Derek T. O'Hagan, Lidia Tajber, Owen I. Corrigan, Edel A. McNeela and Ed C. Lavelle

    Version of Record online : 6 AUG 2012, DOI: 10.1002/eji.201242372

  12. The Development of Self-Emulsifying Oil-in-Water Emulsion Adjuvant and an Evaluation of the Impact of Droplet Size on Performance

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 4, April 2015, Pages: 1352–1361, Ruchi R. Shah, Stephanie Dodd, Mary Schaefer, Mildred Ugozzoli, Manmohan Singh, Gillis R. Otten, Mansoor M. Amiji, Derek T. O'Hagan and Luis A. Brito

    Version of Record online : 19 JAN 2015, DOI: 10.1002/jps.24337

  13. Twelve immunotherapy drugs that could cure cancers

    Immunological Reviews

    Volume 222, Issue 1, April 2008, Pages: 357–368, Martin A. ‘Mac’ Cheever

    Version of Record online : 19 MAR 2008, DOI: 10.1111/j.1600-065X.2008.00604.x

  14. Adjuvants in micro- to nanoscale: current state and future direction

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 8, Issue 1, January/February 2016, Pages: 61–84, Ankur Gupta, Soumen Das, Brian Schanen and Sudipta Seal

    Version of Record online : 6 JUN 2015, DOI: 10.1002/wnan.1354

  15. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles


    Volume 123, Issue 4, April 2015, Pages: 275–288, Atul Srivastava, Devegowda Vishakante Gowda, SubbaRao V. Madhunapantula, Chetan G. Shinde and Meenakshi Iyer

    Version of Record online : 29 JAN 2015, DOI: 10.1111/apm.12351

  16. You have free access to this content
    Regulation of CD4 T-cell receptor diversity by vaccine adjuvants


    Volume 130, Issue 1, May 2010, Pages: 16–22, Christina K. Baumgartner and Laurent P. Malherbe

    Version of Record online : 17 MAR 2010, DOI: 10.1111/j.1365-2567.2010.03265.x

  17. Design, Synthesis, and Evaluation of Novel 1,2,3-Triazole-Tethered Glycolipids as Vaccine Adjuvants

    Archiv der Pharmazie

    Volume 348, Issue 10, October 2015, Pages: 689–703, Debabrata Bhunia, Preethi M. C. Pallavi, Srinivasa Reddy Bonam, Sandeep A. Reddy, Yogesh Verma and M. Sampath Kumar Halmuthur

    Version of Record online : 2 SEP 2015, DOI: 10.1002/ardp.201500143

  18. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses


    Volume 12, Issue 13, April 6, 2016, Pages: 1744–1757, Qi Liu, Jilei Jia, Tingyuan Yang, Qingze Fan, Lianyan Wang and Guanghui Ma

    Version of Record online : 5 FEB 2016, DOI: 10.1002/smll.201503662

  19. You have free access to this content
    From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM

    Cellular Microbiology

    Volume 6, Issue 1, January 2004, Pages: 23–32, Nils Lycke

    Version of Record online : 12 DEC 2003, DOI: 10.1046/j.1462-5822.2003.00338.x

  20. You have free access to this content
    Biomaterials as vaccine adjuvants

    Biotechnology Progress

    Volume 24, Issue 4, July/August 2008, Pages: 807–814, Kim S. Jones

    Version of Record online : 28 AUG 2008, DOI: 10.1002/btpr.10